Episode Details
Back to Episodes
Fidson H1 2025 review
Published 1 year, 1 month ago
Description
Here's my first of 3 episodes on pharma firms H1 2025 earnings on the NGX.
I walk through Fidson H1 2025 earnings as well as my near and mid term price targets.
As always, please note that this is not investment or trading advice.